Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13

Bone

Volumn 44, Issue 2, 2009, Pages 233-242

  Hou, Chun Han ^a,b   Hsiao, Yu Chun ^c   Fong, Yi Chin ^c,d   Tang, Chih Hsin ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

AP 1; BMP 2; Chondrosarcoma; Migration; MMP 13

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENIC PROTEIN 2; COLLAGENASE 3; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN P85; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CHONDROSARCOMA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; HUMAN CELL; ONCOGENE C FOS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; WESTERN BLOTTING; ZYMOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BONE MORPHOGENETIC PROTEIN 2; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHONDROSARCOMA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 13; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 58249098395     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.09.021     Document Type: Article

References (37)

1. Terek R.M., Schwartz G.K., Devaney K., Meitner P.A., Mak S., Verdier P., et al. Chemotherapy and P-glycoprotein expression in chondrosarcoma. J. Orthop. Res. 16 (1998) 585-590
2. Scully S.P., Berend K.R., Qi W.N., and Harrelson M. Collagenase specificity in chondrosarcoma metastasis. Braz. J. Med. Biol. Res. 32 (1999) 885-889
3. Yuan J., Dutton C.M., and Scully S.P. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J. Orthop. Res. 32 (2005) 1467-1474
4. Berend K.R., Toth A.P., Harrelson J.M., Layfield L.J., Hey L.A., and Scully S.P. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. J. Bone Jt. Surg., Am. 80 (1998) 11-17
5. Woodhouse E.C., Chuaqui R.F., and Liotta L.A. General mechanisms of metastasis. Cancer 80 (1997) 1529-1537
6. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002) 161-174
7. Kerkelä E., and Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp. Dermatol. 12 (2003) 109-125
8. Knauper V., López-Otin C., Smith B., Smith B., Knight G., and Murphy G. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271 (1996) 1544-1550
9. Chu C.Y., Cha S.T., Chang C.C., Hsiao C.H., Tan C.T., Lu Y.C., et al. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1alpha-directed invasion of human basal cell carcinoma cells. Oncogene 26 (2007) 2491-2501
10. Reddi A.H. Bone and cartilage differentiation. Curr. Opin. Genet. Dev. 4 (1994) 737-744
11. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
12. Miyazawa K., Shinozaki M., Hara T., Furuya T., and Miyazono K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7 (2002) 1191-1204
13. Langenfeld E.M., Calvano S.E., Abou-Nukta F., Lowry S.F., Amenta P., and Langenfeld J. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24 (2003) 1445-1454
14. Rothhammer T., Poser I., Soncin F., Bataille F., Moser M., and Bosserhoff A.K. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 65 (2005) 448-456
15. Hamdy F.C., Autzen P., Robinson M.C., Horne C.H., Neal D.E., and Robson C.N. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res. 19 (1997) 4427-4431
16. Masuda H., Fukabori Y., Nakano K., Takezawa Y., Suzuki T., and Yamanaka H. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate 54 (2003) 268-274
17. Arnold S.F., Tims E., and Mcgrath B.E. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: Importance of BMP2. Cytokine 11 (1999) 1031-1037
18. Moreau J.E., Anderson K., Mauney J.R., Nguyen T., Kaplan D.L., and Rosenblatt M. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Cancer Res. 67 (2007) 10304-10308
19. Darby S., Cross S.S., Brown N.J., Hamdy F.C., and Robson C.N. BMP-6 over-expression in prostate cancer is associated with increased Id-1 protein and a more invasive phenotype. J. Pathol.s 214 (2008) 394-404
20. Chiu Y.C., Yang R.S., Hsieh K.H., Fong F.C., Way T.D., Lee T.S., et al. Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes. Mol. Pharmacol. 72 (2007) 695-703
21. Fong Y.C., Yang W.H., Hsu S.F., Hsu H.C., Tseng K.F., Hsu C.J., et al. 2-methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J. Orthop. Res. 25 (2007) 1106-1114
22. Tang C.H., Tan T.W., Fu W.M., and Yang R.S. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 29 (2008) 35-43
23. Haynes T., Gutierrez C., Aycinena C.J., Tsonis P.A., and Del Rio-Tsonis K. BMP signaling mediates stem/progenitor cell-induced retina regeneration. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 20305-20380
24. Deng H., Ravikumar T.S., and Yang W.L. Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells. Cancer Lett. 256 (2007) 207-217
25. Downard J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10 (1998) 262-267
26. Ala-aho R., and Kähäri V.M. Collagenases in cancer. Biochimie 87 (2005) 273-286
27. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
28. Chow W.A. Update on chondrosarcomas. Curr. Opin. Oncol. 19 (2007) 371-376
29. Schneiderbauer M.M., Blanchard C., Gullerud R., Harmsen W.S., Rock M.G., Shives T.S., et al. Scapular chondrosarcomas have high rates of local recurrence and metastasis. Clin. Orthop. Relat. Res. 426 (2004) 232-238
30. Bailey J.M., Singh P.K., and Hollingsworth M.A. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J. Cell. Biochem. 102 (2007) 829-839
31. Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev. 3 (2007) 30-38
32. Leeman M.F., Curran S., and Murray G.I. The structure, regulation, and function of human matrix metalloproteinase-13. Crit. Rev. Biochem. Mol. Biol. 37 (2002) 149-166
33. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 18 (2004) 1123-1125
34. Cheng J.C., Chou C.H., Kuo M.L., and Hsieh C.Y. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25 (2006) 7009-7018
35. Thant A.A., Nawa A., Kikkawa F., Ichigotani Y., Zhang Y., Sein T.T., et al. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin. Exp. Metastasis 18 (2000) 423-428
36. Angel P., Hattori K., and Smeal T. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55 (1998) 875-885
37. Wang Z.Q., Liang J., and Schellander K. c-Fos induced osteosarcoma formation in transgenic mice: co-operativity with c-Jun and role of endogenous c-Fos. Cancer Res. 55 (1995) 6244-6251